Last reviewed · How we verify
Rilpivirine formulation G007
At a glance
| Generic name | Rilpivirine formulation G007 |
|---|
| Sponsor | Janssen Sciences Ireland UC |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.